Lessons from the withdrawal of rofecoxib.
Paul A
PA
Dieppe
Shah
S
Ebrahim
Richard M
RM
Martin
Peter
P
Jüni
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D017277:Drug Approval; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D013450:Sulfones
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib